نتایج جستجو برای: شرکت merck
تعداد نتایج: 54045 فیلتر نتایج به سال:
n engl j med 364;19 nejm.org may 12, 2011 1880 the steering committee of an imbalance in cancers. They contacted the DSMBs of IMPROVE-IT and SHARP. Merck was not informed of the imbalance. In July 2008, Merck first became aware of the imbalance after database lock and unblinding and provided that information to the SHARP and IMPROVE-IT steering committees, informing them of the need to notify r...
In this case study, DEMO was applied in a real lean six sigma project. The study was conducted in the Merck organisation, a worldwide pharmaceutical company with a research lab and plant for the production of birth control pills in the Netherlands. The case study was conducted at this site and was intended to solve “order reliability” problems. While the general cause of low order reliability w...
Disclosure of potential conflict of interest: L. Cox is a consultant for Genentech/Novartis, Hollister-Stier, and Stallergenes; is a speaker for Novartis; has received research support from Stallergenes; is on the Board of Directors for the American Board of Allergy and Immunology; and is on the US Food and Drug Administration (FDA)’s Allergenic Product Advisory Committee. H. Nelson is a consul...
Next-generation sequencing (NGS) is quickly replacing other methods for determining expression profiling of RNA as well as single-nucleotide variations within the genomes of both model organisms and human samples. At the Boston facility of Merck Research Laboratories, we concentrate on preparation and sequencing of samples where the research needs cannot be met by commercial venders. These unme...
formation was published in an erratum in the February issue of the Journal [2]. This is an obvious error, because the study, funded by Merck & Co., used the Merck & Co. product RECOMBIVAX HB/H-B-VaxII. The Discussion section discussed only the use of RECOMBIVAX HB/H-B-VaxII as a 2-dose regimen. It was not our intent to suggest that the Twinrix product did not stimulate a good immunologic respon...
Dr Meltzer has received grant/research support from Alcon, Alexza Pharmaceuticals, Amgen, Antigen Labs, Apotex, Astellas, AstraZeneca, Boehringer Ingelheim, Forest, GlaxoSmithKline, Johnson & Johnson, MAP, MEDA, Medimmune, Merck, Novartis, Proctor & Gamble, Schering-Plough, Sepracor, Teva, and UCB. He has served as a consultant/speaker for Alcon, Alexza Pharmaceuticals, Amgen, AstraZeneca, Boeh...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید